Solventum has released its financial results for the second quarter of 2026. 5%. This growth has led Solventum to increase its guidance for the full year, with expectations for higher organic sales growth, adjusted earnings per share, and free cash flow.

Further details on Solventum's financial performance and plans, including the announced separation of its Health Information Systems business segment, are available from the company's report.